Multicenter study on in vitro characterization of dendritic cells.

Multicenter study on in vitro characterization of dendritic cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Multicenter study on in vitro characterization of dendritic cells. Abstract Text:

H Eichler,X D Nguyen,D Roelen,C M Celluzzi,D McKenna,D Pamphilon,A Blair,E J Read,T A Takahashi,Z M Szczepiorkowski, ,

BACKGROUND: There is growing interest in the use of in vitro-expanded dendritic cells (DC) in cancer immunotherapy as cellular-based vaccines. However, the methods used for in vitro preparation vary widely between institutions. Therefore, a strong need exists for standardization, characterization and quality control (QC) of such vaccines. A first prospective multicenter pilot study was performed to investigate basic QC parameters of frozen/thawed DC. The study design was focused on comparison of test results for cell counts, immunophenotyping and cell viability. METHODS: CD14+ monocytes were isolated from three healthy volunteers. The cells were expanded in vitro, matured and cryopreserved using a standardized protocol in one laboratory. The aliquots of cryopreserved DC and a panel of reagents were shipped to eight laboratories worldwide. The objective was to compare the results of non-functional QC assays between sites by testing identical DC vaccines and using a pre-defined test protocol. RESULTS: Measurements of nucleated cell (NC) content of thawed DC vaccines with different types of hematology analyzers (HA) gave similar results for the majority of sites. Immunophenotyping using identical clones of monoclonal antibodies for the detection of surface antigens (i.e. CD1a, CD14, CD16, CD83, CD86 and HLA-DR) provided mostly comparable results between laboratories with an acceptable level of variation. In contrast, highly different results between study sites were generated for measuring the viability of thawed DC by flow cytometry using 7-amino-actinomycin D (7-AAD) dye exclusion. DISCUSSION: In characterizing frozen/thawed DC vaccines, NC counts generated by HA yielded similar results between different laboratories. Furthermore, immunophenotyping of DC vaccines can be standardized between centers, i.e. by using identical reagents. Because of highly variable results between laboratories, 7-AAD viability testing of thawed DC needs to be studied further to identify potential causes for the observed variability.

Multicenter study on in vitro characterization of dendritic cells. Publishing Authors By Initials

H Eichler,XD Nguyen,D Roelen,CM Celluzzi,D McKenna,D Pamphilon,A Blair,EJ Read,TA Takahashi,ZM Szczepiorkowski, ,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Multicenter study on in vitro characterization of dendritic cells. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cytotherapy

VOLUME: 10

Page Numbers: 21-9

Journal Abbreviation:

ISSN: 1477-2566

DAY: 18

MONTH: 01

YEAR: 2008

Multicenter study on in vitro characterization of dendritic cells. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100895309

Multicenter study on in vitro characterization of dendritic cells. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Multicenter study on in vitro characterization of dendritic cells. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Multicenter study on in vitro characterization of dendritic cells.

AFFILIATION: Institute of Transfusion Medicine and Immunology, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Heidelberg, Germany.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cytotherapy

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Multicenter study on in vitro characterization of dendritic cells Related Publications

• How we approach an apheresis request for a Category III, Category IV, or noncategorized indication.
• Multicenter study on in vitro characterization of dendritic cells.